The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Flagship Pioneering Unveils Kintai Therapeutics
Finance

Flagship Pioneering Unveils Kintai Therapeutics

APR 16, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD
Clinical & Manufacturing

MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute GvHD

APR 11, 2019
SkinBiotix® Shows Efficacy in First Human Study
Pharma & Human Health

SkinBiotix® Shows Efficacy in First Human Study

APR 8, 2019
Interview With Aoife Brennan, CEO, Synlogic Inc
Biotics and Supplements

Interview With Aoife Brennan, CEO, Synlogic Inc

APR 7, 2019
C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage
Pharma & Human Health

C3J Therapeutics Announces Issuance of U.S. Patent Covering Synthetic Bacteriophage

APR 3, 2019
The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms
Clinical & Manufacturing

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

APR 3, 2019
Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome
Finance

Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome

APR 2, 2019
Holobiome Announces Second Collaboration with Johnson & Johnson Innovation
Finance

Holobiome Announces Second Collaboration with Johnson & Johnson Innovation

APR 2, 2019
New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students
Biotics and Supplements

New Randomized Double-Blind Placebo-Controlled Trial Finds Probiotics to Benefit Mood and Quality of Sleep in Healthy Students

APR 1, 2019
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
Finance

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics

APR 1, 2019
5-Minute Microbiome Science Roundup: March 2019
Editor's Choice

5-Minute Microbiome Science Roundup: March 2019

APR 1, 2019